This novel study demonstrated that an increased expression of FOXO3 may be an unfavorable clinical factor with diagnostic and prognostic value in HCC, being related to tumor development, poor OS and a high probability of invasion. This evidence concerns the gene FOXO3 and hepatocellular carcinoma.